HS
NVLN

Horan Securities’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Horan Securities’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12
Closed – – 250
2019
Q3 		$0 Hold
12
– – ﹤0.01% 305
2019
Q2 		$0 Hold
12
– – ﹤0.01% 302
2019
Q1 		$0 Hold
12
– – ﹤0.01% 246
2018
Q4 		$0 Hold
12
– – ﹤0.01% 239
2018
Q3 		$0 Hold
12
– – ﹤0.01% 228
2018
Q2 		$0 Hold
12
– – ﹤0.01% 236
2018
Q1 		$0 Hold
12
– – ﹤0.01% 218
2017
Q4 		$0 Hold
12
– – ﹤0.01% 212
2017
Q3 		$0 Hold
12
– – ﹤0.01% 198
2017
Q2 		$0 Hold
12
– – ﹤0.01% 190
2017
Q1 		$0 Buy
+12
New +$123 ﹤0.01% 184

Other funds holding NVLN

SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Horan Securities's NVLN Position: Q4 2019 in Review

Horan Securities sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q4 2019, closing a stake of 12 shares.

Horan Securities first reported a position in NVLN in Q1 2017 and held it in 11 quarters. The position peaked at $0 in Q3 2019. 7 funds tracked by Wall St. Rank hold NVLN as of Q4 2019.

  • Horan Securities reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q4 2019 after selling out during the quarter.
  • Horan Securities sold 12 Novelion Therapeutics Inc. Common Shares shares in Q4 2019.
  • Horan Securities first reported a position in Novelion Therapeutics Inc. Common Shares in Q1 2017 and held it in 11 quarters.
  • Horan Securities's Novelion Therapeutics Inc. Common Shares position peaked at $0 in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q4 2019.

Based on Horan Securities's 13F filing for Q4 2019, filed 5 Feb 2020.